CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Sees Significant Increase in Short Interest

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) saw a large increase in short interest in November. As of November 15th, there was short interest totalling 190,400 shares, an increase of 2,438.7% from the October 31st total of 7,500 shares. Based on an average daily volume of 241,500 shares, the short-interest ratio is presently 0.8 days.

CNBX Pharmaceuticals Stock Performance

Shares of CNBX remained flat at $0.01 during trading hours on Wednesday. The stock had a trading volume of 51 shares, compared to its average volume of 185,225. The stock has a 50 day moving average price of $0.01 and a 200-day moving average price of $0.01. CNBX Pharmaceuticals has a one year low of $0.01 and a one year high of $0.02.

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.